Overview
Profile
Experience
Kim & Chang (1997-Present)
S.Y. Cha Patent Office (1995.12.-1996.12.)
Representative MattersView All
- Represented a Fortune 100 pharmaeceutical compnay in a patent invalidation and infringement actions relating to pharmaceutical products
- Represented a biotech company in patent infringement action relating to animal cloning technology and successfully settled the case
- Represented a major pharmaceutical company in patent scope-confirmation actions relating to pharmaceutical products and prevailed
- Represented a global electronics company in a patent infringement action relating to electronic materials and successfully settled the case
- Patent litigation and trials
- Patent prosecution and appeals
- Patent-related pharmaceutical regulatory matters
- Patent-related matters regarding fair trade law
Representative ActivitiesView All
Awards
- Client Choice Awards - Practice (Lexology, 2022)
Publications/Activities
- Speaker, "Second medical use inventions in Korea," 2014 AIPPI Trilateral Meeting (2014.6.)
- Speaker, “Settlement of Pharma Disputes and Competition Law in Korea,” 2012 AIPPI Congress (2012.10.)
- "Working it out-New Korean Law Governing Work-for-hire Inventions," (Patent World, May 2006)
- "Drug Data Given Strong Protection," (Managing Intellectual Property, March 2005)
- “A Novel Strong Promoter of the groEX Operon of Symbiotic Bacteria in Amoeba proteus,” Gene 128, 43-49 (1994)
Education
Franklin Pierce Law Center (MIP, 2002)
Graduate School of Education, Seoul National University (Completion of course work for a Ph.D., Cell Biology, 1994)
Graduate School of Education, Seoul National University (M.S., Cell Biology, 1992)
University of Tennessee (Research Scholar, 1991)
College of Education, Seoul National University (B.S., Biology, summa cum laude, 1990)
Qualifications
Admitted to patent bar, Korea, 1995
Languages
Korean and English
Insights
-
Recognitions
Kim & Chang Named in IAM Patent 1000: The World's Leading Patent Professionals 2023
2023.06.26 -
Recognitions
Eighteen Kim & Chang Professionals Selected as Winners of Client Choice Awards 2022
2022.11.15 -
News
2022 AIPPI World Congress
2022.09.14 -
Newsletters
Korean Patent Court Confirms for the First Time That a Pharmaceutical Compound Patent Covers Generic Prodrugs
2022.03.10 -
Newsletters
Despite Recent Court Losses, Korean Generics Continue to Argue for Limiting PTE Scope
2020.02.12 -
News
AIPPI Trilateral Meeting in Seoul, June 13-15, 2014
2014.06.30